R

Restore Vision

3 employees

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
retinitis pigmentosa
Therapeutics
AAV
ophthalmology
Gene therapy
Health Care

Date founded

2016

Funding rounds raised

Total raised

$2.7M

from 3 investors over 3 rounds

R

Restore Vision raised $2.6M on February 3, 2022

Investors: Remiges Ventures, Inc. and ANRI

R

Restore Vision raised $2.7M on February 3, 2022

Investors: KOBE Biomedical Innovation Cluster

FAQ